UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors

Pancreas, 2017-11, Vol.46 (10), p.1354-1358

2017

Volltextzugriff (PDF)

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

Frontiers in oncology, 2023-05, Vol.13, p.1163768-1163768

2023

Volltextzugriff (PDF)

Newly qualified doctors' views about whether their medical school had trained them well: questionnaire surveys

BMC medical education, 2007-10, Vol.7 (1), p.38-38, Article 38

2007

Volltextzugriff (PDF)

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

Endocrine Connections, 2017-11, Vol.6 (8), p.876-885

2017

Volltextzugriff (PDF)

'It gives you an understanding you can't get from any book.' The relationship between medical students' and doctors' personal illness experiences and their performance: a qualitative and quantitative study

BMC medical education, 2007-12, Vol.7 (1), p.50-50, Article 50

2007

Volltextzugriff (PDF)

Fatigue in non-small cell lung cancer (NSCLC) patients treated with immunotherapy, is there a role for physical activity?

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S48

2021

Volltextzugriff (PDF)

Oncology and medical education-past, present and future

Ecancermedicalscience, 2016, Vol.10, p.ed54-ed54

Cave, Judith

2016

Volltextzugriff (PDF)

Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S53

2023

Volltextzugriff (PDF)

122 - Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S53-S53

2023

Volltextzugriff (PDF)

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1511-1521

2016

Volltextzugriff (PDF)

Explicitly linking teaching and assessment of communication skills

Medical teacher, 2007-05, Vol.29 (4), p.317-322

2007

Volltextzugriff (PDF)

208 SynthEtic LEthal Cancer Therapy in mesothelioma (SELECTmeso): a molecularly stratified multi-arm phase II platform trial for patients with relapsed malignant mesothelioma

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107769, Article 107769

2024

Volltextzugriff (PDF)

135 - Real world use of atezolizumab in the management of small cell lung cancer: experience from a UK teaching hospital

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S62-S62

2022

Volltextzugriff (PDF)

Real world use of atezolizumab in the management of small cell lung cancer: experience from a UK teaching hospital

Lung cancer (Amsterdam, Netherlands), 2022-03, Vol.165, p.S62

2022

Volltextzugriff (PDF)

A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS8600-TPS8600

2023

Volltextzugriff (PDF)

The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis

Journal of clinical pathology, 2016-07, Vol.69 (7), p.612-618

2016

Volltextzugriff (PDF)

THE COMPETENT NOVICE: Dealing with complaints

BMJ. British medical journal (International ed.), 2008-02, Vol.336 (7639), p.326

International edition, 2008

Volltextzugriff (PDF)

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study

International immunopharmacology, 2022-09, Vol.110, p.108985-108985, Article 108985

2022

Volltextzugriff (PDF)

76 - Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S33-S33

2023

Volltextzugriff (PDF)

Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.S33

2023

Volltextzugriff (PDF)

Ethnic stereotypes and the underachievement of UK medical students from ethnic minorities: qualitative study

BMJ, 2008-09, Vol.337 (aug18 1), p.a1220-a1220

International edition, 2008

Volltextzugriff (PDF)

Easing the transition from student to doctor: How can medical schools help prepare their graduates for starting work?

Medical teacher, 2009-05, Vol.31 (5), p.403-408

2009

Volltextzugriff (PDF)

NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.646-646

2023

Volltextzugriff (PDF)

Recent advances in the molecular landscape of lung neuroendocrine tumors

Expert review of molecular diagnostics, 2019-04, Vol.19 (4), p.281-297

2019

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(94)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinically Significant Differences in Ki-67 Proliferation Index Between Primary and Metastases in Resected Pancreatic Neuroendocrine Tumors

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

Newly qualified doctors' views about whether their medical school had trained them well: questionnaire surveys

Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

'It gives you an understanding you can't get from any book.' The relationship between medical students' and doctors' personal illness experiences and their performance: a qualitative and quantitative study

Fatigue in non-small cell lung cancer (NSCLC) patients treated with immunotherapy, is there a role for physical activity?

Oncology and medical education-past, present and future

Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma

122 - Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

Explicitly linking teaching and assessment of communication skills

208 SynthEtic LEthal Cancer Therapy in mesothelioma (SELECTmeso): a molecularly stratified multi-arm phase II platform trial for patients with relapsed malignant mesothelioma

135 - Real world use of atezolizumab in the management of small cell lung cancer: experience from a UK teaching hospital

Real world use of atezolizumab in the management of small cell lung cancer: experience from a UK teaching hospital

A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO

The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis

THE COMPETENT NOVICE: Dealing with complaints

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study

76 - Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis

Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis

Ethnic stereotypes and the underachievement of UK medical students from ethnic minorities: qualitative study

Easing the transition from student to doctor: How can medical schools help prepare their graduates for starting work?

NET-02 final results: A randomised, phase II trial of liposomal irinotecan (nal-IRI)/5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line (2L) therapy in patients (pts) with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (PD-EP-NEC)

Recent advances in the molecular landscape of lung neuroendocrine tumors

Aktive Filter

Suchergebnisse filtern